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IgG4-related sclerosing cholangitis (IgG4-SC) is one of the most common extra-pancreatic manifestation of IgG4-related disease
(IgG4-RD) and is clinically distinct from primary sclerosing cholangitis (PSC). IgG4-RD is an increasingly recognized immune-
mediated ﬁbroinﬂammatory systemic disease, mostly aﬀecting middle-aged and older male populations that can aﬀect multiple
organs. *e presence of extra-biliary clinical manifestations of IgG4-RD, such as parotid and lacrimal swelling, lymphadenopathy,
autoimmune pancreatitis, and retroperitoneal ﬁbrosis, if present could provide important clues to diagnosis. High serum IgG4 levels,
characteristic radiological (e.g., sausage-shaped pancreas or periaortitis) or biopsy ﬁndings (high percentage of IgG4+ plasma cells,
lymphoplasmacytic inﬁltrate, storiform ﬁbrosis, or obliterative phlebitis) in the setting of these features is diagnostic of this disease
process. However, isolated IgG4-SCmight be a diagnostic challenge, and the distinction is important as management of this disorder
is vastly diﬀerent from other causes of cholangitis such as PSC. Systemic corticosteroid therapy is the mainstay of therapy.
1. Introduction
Immunoglobulin G4-related sclerosing cholangitis (IgG4-
SC) is a relatively uncommon but increasingly recognized
entity. It was ﬁrst described in 2001 by Hamano et al. [1] with
a landmark study demonstrating elevated levels of serum
IgG4 in patients with sclerosing cholangitis [1–4]. It is
characterized by systemic inﬂammatory and sclerosing le-
sions with massive inﬁltration of IgG4-positive lymphocytes
involving multiple organ systems, such as the eyes, salivary
glands, lacrimal glands, lungs, pancreas, kidneys, retro-
peritoneum, and vascular system [2, 5]. Sclerosing chol-
angitis (SC) is one of the common organ manifestations of
IgG4-related disease (IgG4-RD), aﬀecting approximately
60% of patients with this systemic disease [5]. It may occur as
a part of the systemic manifestation of IgG4-RD, often
associated with type 1 autoimmune pancreatitis [1, 2, 6].
Isolated IgG4-SC can occur rarely and pose a diagnostic
challenge [5, 6].
2. Case Presentation
An 81-year-old male presented to the clinic with yellowish
discoloration of skin and urine for 2 weeks. He denied any
fever, abdominal pain, nausea, vomiting, melena, hema-
tochezia, or acholic stools. Past medical history was sig-
niﬁcant for hypertension, hyperlipidemia, diabetes mellitus
type II, coronary artery disease, and chronic kidney disease
stage IV. He reported recent loss of appetite but denied any
signiﬁcant weight changes. Ultrasound ordered by primary
care physician showed intra- and extra-hepatic biliary di-
lation with distension of gall bladder without cholelithiasis.
He was sent to the emergency department (ED) for further
evaluation.
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On examination, blood pressure was 133/60mmHg,
heart rate was 75 beats per minute, respiratory rate was 23
breaths per minute, temperature was 97.7°F, and oxygen
saturation was 98% in room air. He had mild icteric sclera,
and chronic venous stasis changes in bilateral lower ex-
tremities were noted. Bowel sounds were normal, and no
hepatosplenomegaly or abdominal tenderness was noted on
exam.
Laboratory investigations showed a hemoglobin count of
11 g/dl, white blood cell count of (WBC) 3800 cell/mm3, and
platelet count of 214,000/mm3. Alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) were elevated
at 326 and 321 IU/L, respectively. Total bilirubin was
3.1mg/dl with direct bilirubin of 1.8mg/dl. Alkaline
phosphatase (ALP) was 1,219 IU/L with lipase 250 IU/L.
Renal function tests were at baseline at 1.72mg/dl (base-
line 1.7–1.9mg/dl). Recent upper and lower endoscopy (1
month earlier) did not show signiﬁcant abnormalities, ex-
cept for mild antral gastropathy. A computed tomography
(CT) scan of abdomen and pelvis revealed stable pelvic
adenopathy with largest lymph node measuring 4.4×1.7 cm
(which was noted on the earlier CT scan as well). *e
pancreatic tissue and abdominal vessels appeared normal.
With concern for underlying malignancy, a lymph node
biopsy was performed. Endoscopic retrograde of chol-
angiopancreatography revealed distal common bile duct
stricture of 3 cm without obstruction, for which a biliary
stent was placed. No pancreatic lesions were observed, and
biliary brushings were negative for malignancy.
*e patient returned to the ED two months later; this
time with a fever (102°F), nausea, and right upper quadrant
pain for 2 days. Complete blood counts revealed elevated
white cell count of 18,700/mm3. AST, ALT, and bilirubin
levels were within normal limits, and ALP was elevated at
127 IU/L. *e CT scan of abdomen revealed intrahepatic
biliary ductal dilatation and gall bladder wall thickening with
pericholecystic inﬂammatory stranding with normal pan-
creas (Figure 1). He was started on broad-spectrum anti-
biotics with piperacillin-tazobactam. Urgent surgical
decompression with percutaneous drain placement was
performed for stent blockage (with re-stent placement) and
bile duct stricture from unknown etiology.
Meanwhile, histopathology from the earlier right iliac
lymph node biopsy revealed sinus histiocytic aggregates
interlaced with lymphocytes and plasma cells (Figure 2(a)),
majority of cellular constituents being plasma cells, char-
acterized by oval cellular contours and eccentrically located
nuclei (Figure 2(b)); this was conﬁrmed by diﬀuse immu-
noreactivity for CD138 (Figure 2(c)). Chromogenic in situ
hybridization for kappa light chain (Figure 3(a)) and lambda
light chain (Figure 3(b)) showed a mixture of kappa and
lambda-bearing cells (approximate kappa to lambda ratio of
3 :1); this ﬁnding suggested that the plasma cells were re-
active in nature, arguing against the possibility of a plasma
cell neoplasm. In situ hybridization for EBV-encoded RNA
(EBER) was interpreted as negative.
As there was no evidence to suggest a lymphoma or
a plasma cell neoplasm, a diagnosis of IgG-related disease
was considered. Additional immunohistochemistry showed
that the plasma cells present expressed predominantly IgG
(Figure 3(c)); of these, the majority (over 60%) were reactive
for IgG4 (Figure 3(d)). Serum protein electrophoresis and
immunoﬁxation showed polyclonal increase in IgG with no
monoclonal proteins. Serum immunoglobulin (Ig) G levels
were high (3390mg/dl) with normal IgA and IgM. IgG
subclasses were also high with IgG1 of 1800, IgG2 975, IgG3
324, and IgG4 729mg/dl.
A diagnosis of IgG4-related sclerosing cholangitis was
made, and he was started on prednisone 40mg daily for 6
weeks. A follow-up CT scan of abdomen after a month
revealed signiﬁcant reduction in the size of his pelvic lymph
nodes with largest lymph node measuring 1.8× 0.7 cm
(Figure 4). Endoscopic retrograde cholangiography (ERC)
performed revealed resolution of stricture (Figure 5). *e
biliary stent was removed following resolution of the
stricture. He remains on prednisone 20mg daily with close
rheumatology follow-up. Rituximab therapy is being con-
sidered as a steroid-sparing agent.
3. Description
Although reported as a relatively rare disease with a preva-
lence of 100 per 100,000 adults based on limited studies done
in Japan [7], the prevalence of IgG4-RD is likely higher due
to underdiagnoses. Fortunately, increasing recognition
among various specialties due to its multisystem in-
volvement has been noted in recent years [8]. High index of
suspicion for IGg4-RD should be raised in the setting of
a constitution of clinical features such as pancreatitis
(present in 60% of IgG4-RD) of unknown origin, sclerosing
cholangitis (13% of IgG4-RD), or bilateral salivary and/or
lacrimal gland enlargement (34% of IgG4-RD) [5, 9].
Proximal IgG4-SC (hilar and intrahepatic bile duct) may
occur solely or in association with pancreatitis, whereas
isolated lower duct IgG4-SC, as in our case, is rare and might
pose a diagnostic challenge. It is more commonly observed
with IgG4-RD aﬀecting organs outside the pancreatobiliary
system [5].
*e diﬀerentiation of IgG4-SC from primary sclerosing
cholangitis (PSC) and cholangiocarcinoma is clinically very
important as IgG4-SC usually has a good response to steroid
therapy [10]. IgG-SC patients are generally older than PSC
Figure 1: Gall bladder wall thickening with pericholecystic in-
ﬂammatory stranding concerning for acute cholecystitis with
normal pancreas.
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patients, with more than 90% being diagnosed at or above 60
years of age [5, 6, 8, 9]. Also, unlike other autoimmune
conditions, IgG4-SC is more common inmales (M : F� 4 :1).
Imaging features suggestive of PSC are multifocal intra-
hepatic duct involvement with beaded pattern secondary to
short segmental strictures, whereas IgG4-SC has prominent
wall thickening in the bile duct [10]. Similarly, imaging
features of cholangiocarcinoma include solitary lesion with
irregular margins with eccentric wall thickening and in-
visible bile duct lumen in the involved segment [10, 11].
*e Japanese IgG4-RD committee has recently published
a diagnostic criterion for IgG4-SC (2012) based on a com-
bination of 4 features: (1) characteristic biliary imaging
ﬁndings—diﬀuse swelling or organ mass, (2) elevation of
serum IgG4 concentrations (≥135mg/dl), (3) coexistence of
IgG4-related diseases, and (4) characteristic histopatho-
logical features of steroid therapy are optional criteria to
conﬁrm accurate diagnosis of IgG4-SC [8, 12]. Typical
histopathologic features of IgG4-RD include marked lym-
phocytic and plasmacyte inﬁltration with high percentage of
(a) (b) (c)
Figure 2: Biopsy fragment of right iliac lymph node showing sinus histiocytic aggregates interlaced with lymphocytes and plasma cells. (a)
H&E stain, 100x original magniﬁcation. Small cells within the lymph nodes, showing morphologic features of plasma cells, characterized by
an oval cellular morphologic, and eccentrically placed nuclei. (b) H&E stain, 200x original magniﬁcation. Majority of cellular constituents
conﬁrmed to be plasma cells, as demonstrated by diﬀuse reactivity for CD138 by immunohistochemistry. (c) 200x original magniﬁcation.
(a) (b)
(c) (d)
Figure 3: Chromogenic in situ hybridization showing a mixture of kappa-bearing plasma (a) and lambda-bearing plasma (b) cells, with an
approximate kappa to lambda ratio of 3–4 to 1, appropriate for a physiologic/reactive phenomenon, without evidence of obvious restriction.
Plasma cells expressed predominantly IgG (c); of these, the majority (over 60%) were immunoreactive for IgG4 (d) (200x original
magniﬁcation).
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IgG4-positive plasma cells, storiform ﬁbrosis, and obliter-
ative phlebitis [13]. In our case, the ﬁrst two histopathologic
features were observed.
Glucocorticoids remain the mainstay of therapy for
remission induction in all patients with active IgG4-RD.
Retrospective studies performed have shown good response
to immunosuppression (prednisone at a dose of 30–40mg
per day), which generally leads to a rapid induction of
disease remission [2, 5]. In refractory cases or patients with
diﬃculty in tapering prednisone (usually below 5mg/day),
addition of steroid-sparing agents such as rituximab might
be indicated. Although the natural history and long-term
outcomes are not well understood, majority of patients tend
to relapse, and most patients have a chronic disease course
[14]. Hence, close follow-up with rheumatology is
recommended.
4. Conclusion
Isolated IgG4-SC is a diﬃcult entity to diagnose with vague
presentation and overlapping symptoms with PSC, chol-
angiocarcinoma, other autoimmune conditions, and ma-
lignancy. Appropriate clinical, serologic, radiologic, and
pathologic features may aid in diagnosis, although none in
isolation is diagnostic. Glucocorticoids are the mainstay of
therapy, and rituximab might be added as a steroid-sparing
agent, especially in refractory or steroid-dependent cases.
Close follow-up is recommended due to its chronic and
relapsing course.
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